As of 2024-12-14, the EV/EBITDA ratio of Insmed Inc (INSM) is -19.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 13,335.70 mil USD. INSM's TTM EBITDA according to its financial statements is -681.65 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 16.5x | 15.9x |
| Forward P/E multiples | 15.3x - 17.2x | 15.5x |
| Fair Price | (61.21) - (65.78) | (62.73) |
| Upside | -185.5% - -191.8% | -187.6% |
| Date | EV/EBITDA |
| 2024-12-11 | -20.24 |
| 2024-12-10 | -19.82 |
| 2024-12-09 | -19.86 |
| 2024-12-06 | -20.55 |
| 2024-12-05 | -20.53 |
| 2024-12-04 | -20.54 |
| 2024-12-03 | -19.77 |
| 2024-12-02 | -19.77 |
| 2024-11-29 | -20.49 |
| 2024-11-27 | -20.68 |
| 2024-11-26 | -20.63 |
| 2024-11-25 | -20.21 |
| 2024-11-22 | -19.96 |
| 2024-11-21 | -20.14 |
| 2024-11-20 | -19.84 |
| 2024-11-19 | -20.11 |
| 2024-11-18 | -18.25 |
| 2024-11-15 | -18.16 |
| 2024-11-14 | -19.47 |
| 2024-11-13 | -19.29 |
| 2024-11-12 | -19.17 |
| 2024-11-11 | -19.61 |
| 2024-11-08 | -20.07 |
| 2024-11-07 | -19.58 |
| 2024-11-06 | -19.89 |
| 2024-11-05 | -18.95 |
| 2024-11-04 | -18.63 |
| 2024-11-01 | -18.70 |
| 2024-10-31 | -18.42 |
| 2024-10-30 | -19.21 |
| 2024-10-29 | -19.39 |
| 2024-10-28 | -19.65 |
| 2024-10-25 | -19.39 |
| 2024-10-24 | -19.58 |
| 2024-10-23 | -19.65 |
| 2024-10-22 | -20.10 |
| 2024-10-21 | -19.73 |
| 2024-10-18 | -20.33 |
| 2024-10-17 | -20.26 |
| 2024-10-16 | -20.88 |
| 2024-10-15 | -20.36 |
| 2024-10-14 | -20.47 |
| 2024-10-11 | -20.33 |
| 2024-10-10 | -19.58 |
| 2024-10-09 | -19.13 |
| 2024-10-08 | -19.50 |
| 2024-10-07 | -19.27 |
| 2024-10-04 | -19.73 |
| 2024-10-03 | -19.50 |
| 2024-10-02 | -19.93 |